1. Home
  2. OCFT vs IVA Comparison

OCFT vs IVA Comparison

Compare OCFT & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCFT
  • IVA
  • Stock Information
  • Founded
  • OCFT 2015
  • IVA 2011
  • Country
  • OCFT China
  • IVA France
  • Employees
  • OCFT N/A
  • IVA N/A
  • Industry
  • OCFT Computer Software: Programming Data Processing
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCFT Technology
  • IVA Health Care
  • Exchange
  • OCFT Nasdaq
  • IVA Nasdaq
  • Market Cap
  • OCFT 169.6M
  • IVA 162.8M
  • IPO Year
  • OCFT 2019
  • IVA 2020
  • Fundamental
  • Price
  • OCFT $6.07
  • IVA $3.36
  • Analyst Decision
  • OCFT
  • IVA Strong Buy
  • Analyst Count
  • OCFT 0
  • IVA 4
  • Target Price
  • OCFT N/A
  • IVA $10.50
  • AVG Volume (30 Days)
  • OCFT 77.6K
  • IVA 17.0K
  • Earning Date
  • OCFT 05-20-2025
  • IVA 03-26-2025
  • Dividend Yield
  • OCFT N/A
  • IVA N/A
  • EPS Growth
  • OCFT N/A
  • IVA N/A
  • EPS
  • OCFT N/A
  • IVA N/A
  • Revenue
  • OCFT $307,997,287.00
  • IVA $14,591,573.00
  • Revenue This Year
  • OCFT N/A
  • IVA $18.05
  • Revenue Next Year
  • OCFT $6.37
  • IVA $46.74
  • P/E Ratio
  • OCFT N/A
  • IVA N/A
  • Revenue Growth
  • OCFT N/A
  • IVA N/A
  • 52 Week Low
  • OCFT $0.87
  • IVA $1.53
  • 52 Week High
  • OCFT $6.90
  • IVA $3.90
  • Technical
  • Relative Strength Index (RSI)
  • OCFT 49.29
  • IVA 61.22
  • Support Level
  • OCFT $5.40
  • IVA $2.88
  • Resistance Level
  • OCFT $6.45
  • IVA $3.45
  • Average True Range (ATR)
  • OCFT 0.33
  • IVA 0.26
  • MACD
  • OCFT -0.10
  • IVA 0.03
  • Stochastic Oscillator
  • OCFT 47.86
  • IVA 81.36

About OCFT OneConnect Financial Technology Co. Ltd.

OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: